arrow
S

Sabine Siesling

Netherlands Comprehensive Cancer Organisation
H指数:61
被引数:2.6万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Early detection of symptoms using electronic patient-reported outcomes and a Fitbit to optimise care in metastatic breast cancer: study protocol of the SYMPHA trial

使用电子患者报告结局和Fitbit进行症状早期检测以优化转移性乳腺癌的护理:SYMPHA试验的研究方案

2026-10-300
OAAI
Impact of Reimbursement on the Utilisation of Gene Expression Profiles and Chemotherapy Decision-Making in Dutch Breast Cancer Patients: A Population-Based Study

报销对荷兰乳腺癌患者基因表达谱的利用和化疗决策的影响: 一项基于人群的研究

2026-06-040
OAAI
Development and validation of prediction models for health-related quality of life outcomes after breast cancer surgery and reconstruction

乳腺癌手术和重建术后健康相关生活质量结局预测模型的开发与验证

2026-02-100
OAAI
Acute toxicity and quality of life after 5-fraction versus 15-fraction adjuvant radiotherapy following conventional or oncoplastic breast-conserving surgery − a real-world prospective cohort study

急性毒性和生活质量:比较5分次与15分次辅助放疗在常规或肿瘤整形保乳术后应用的真实世界前瞻性队列研究

2025-11-300
OAAI
Global variation in patterns of care and time to initial treatment for breast, cervical, and ovarian cancer from 2015 to 2018 (VENUSCANCER): a secondary analysis of individual records for 275 792 women from 103 population-based cancer registries in 39 countries and territories

2015年至2018年全球范围内乳腺癌、宫颈癌和卵巢癌的护理模式及初始治疗时间差异(VENUSCANCER):一项基于39个国家和地区103个基于人群的癌症登记处275,792名女性个体记录的二次分析

2025-10-220
OAAI
A Goal Without a Plan Is Just a Wish—Creating a Personalized Aftercare Plan for Breast Cancer Patients Supported by the Breast Cancer Aftercare Decision Aid

没有计划的目標只是一个愿望——为乳腺癌患者创建个性化的随访计划,该计划由乳腺癌随访决策辅助工具支持。

2025-10-010
OAAI
Overall survival of patients with de Novo HER2-positive metastatic breast cancer in the Netherlands from 2008 to 2017: A population-based cohort study of systemically treated patients

2008年至2017年荷兰新诊断HER2阳性转移性乳腺癌患者的总生存期:一项针对系统性治疗患者的基于人群的队列研究

2025-06-010
OAAI
Five-year conditional relative survival up to 10 years post-diagnosis among adolescent and young adult breast cancer patients by age, stage, and receptor subtype

诊断后10年内,按年龄、分期和受体亚型划分的青少年及青年乳腺癌患者的5年条件相对生存率

2025-03-310
OAAI
Patient-reported outcomes after immediate and delayed DIEP-flap breast reconstruction in the setting of post-mastectomy radiation therapy-results of the multicenter UMBRELLA breast cancer cohort

在乳房切除术后放射治疗的情况下,立即和延迟DIEP皮瓣乳房重建后的患者报告的结果-多中心伞形乳腺癌队列的结果

2025-02-030
OAAI